Therapeutic effects of adding rimactane (rifampicin) 450 milligrams daily or 1200 milligrams once monthly in a single dose to dapsone 50 milligrams daily in patients with lepromatous leprosy.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002986:Clinical Trials as Topic; D003622:Dapsone / Q000008:administration & dosage*; D004359:Drug Therapy, Combination / Q000009:adverse effects; D005260:Female; D006801:Humans; D007918:Leprosy / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009166:Mycobacterium leprae / Q000302:isolation & purification; D009297:Nasal Mucosa / Q000382:microbiology; D012293:Rifampin / Q000008:administration & dosage*; D012867:Skin / Q000382:microbiology / Q000473:pathology
D003622:Dapsone; D012293:Rifampin